Cambridge, USA-based Vesalius Therapeutics has entered into a multi-target strategic alliance with the UK’s GSK to discover ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

GSK celebrates 100 years in India with former MDs, highlighting resilience and reinvention in the pharmaceutical industry.

GSK is the latest to turn its back on prominent industry lobbying group Biotechnology Innovation Organization (BIO), ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

GSK Pharmaceuticals India focuses on affordable general medicine access amidst premiumisation trend, discussed by managing ...

Though prescribing climate-friendly dry powder inhalers is environmentally sound, some experts warn certain patients may be ...

DelveInsight's Dermatological Drugs Market Insights report provides the current and forecast market analysis, individual ...

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

Belgium has solidified its position as a European leader in pharmaceutical research and development with a daily investment ...

GSK has spent slightly more on lobbying this year compared with 2023. The company spent $3.87 million in the first three ...